熱門資訊> 正文
下一篇Cure GAAP每股收益为-11.29美元
2025-08-09 02:04
- NextCure press release (NASDAQ:NXTC): Q2 GAAP EPS of -$11.29.
- Cash, cash equivalents, and marketable securities as of June 30, 2025 were $35.3 million as compared to $68.6 million as of December 31, 2024. The decrease of $33.3 million was primarily due to cash used to fund operations. We expect current financial resources to be sufficient to fund operating expenses and capital expenditures into mid-2026.
More on NextCure
- Seeking Alpha’s Quant Rating on NextCure
- Historical earnings data for NextCure
- Financial information for NextCure
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
